Expression of ADAM-15 in rat myocardial infarction

Ji Ke Li1, Wen Juan Du, Shu Lin Jiang

  • 1Department of Cardiology Surgery, The Second Clinical College of Harbin Medical University, Harbin, China.

Insights

Disintegrin and metalloprotease-15 (ADAM-15) expression increases after myocardial infarction (MI) in rats, peaking at 3 days. ADAM-15 is localized in cardiac myocytes and macrophages, suggesting its role in cardiac remodeling and inflammation post-MI.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Inflammation Research

Background:

  • Myocardial infarction (MI) significantly impacts cardiac function and involves complex inflammatory and remodeling processes.
  • A disintegrin and metalloprotease-15 (ADAM-15) is implicated as a regulator of inflammation and tissue repair, with potential roles in cardiac pathology.

Purpose of the Study:

  • To investigate the temporal expression and localization of ADAM-15 in a rat model of myocardial infarction.
  • To elucidate the potential involvement of ADAM-15 in the inflammatory response and cardiac remodeling following MI.

Main Methods:

  • Myocardial infarction was induced in Wistar rats via coronary artery ligation.
  • ADAM-15 mRNA and protein levels were quantified using RT-PCR and Western blot at 1, 3, 7, and 14 days post-MI.
  • Immunohistochemistry was employed to determine the cellular localization of ADAM-15 protein.

Main Results:

  • ADAM-15 expression was significantly upregulated in the infarcted heart compared to sham controls.
  • Expression levels peaked at day 3 post-MI, followed by a gradual decrease at days 7 and 14.
  • ADAM-15 protein was primarily detected in cardiac myocytes within the border zone and in macrophages in the border and infarcted areas.

Conclusions:

  • ADAM-15 expression is dynamically regulated following myocardial infarction in rats.
  • The localization of ADAM-15 suggests its involvement in the inflammatory cell infiltration and tissue remodeling characteristic of MI.
  • ADAM-15 represents a potential therapeutic target for managing cardiac dysfunction after MI.

Related Concept Videos